Key stats
About FULLGOAL FUND MANAGEMENT CO LTD FG CSI HEALTH CARE 50 ETF
Home page
Inception date
Mar 16, 2020
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Fullgoal Fund Management Co., Ltd.
ISIN
CNE100003VV1
Tightly track the index of the target, and pursue the minimization of tracking deviation and tracking err
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
515950 assets under management is 583.78 M CNY. It's fallen 11.27% over the last month.
515950 fund flows account for −171.95 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
515950 shares are issued by Fullgoal Fund Management Co., Ltd. under the brand Fullgoal. The ETF was launched on Mar 16, 2020, and its management style is Passive.
515950 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
515950 follows the CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
515950 price has risen by 2.07% over the last month, and its yearly performance shows a 4.51% increase. See more dynamics on 515950 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 1.54% over the last month, showed a −0.49% decrease in three-month performance and has increased by 4.90% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 1.54% over the last month, showed a −0.49% decrease in three-month performance and has increased by 4.90% in a year.
515950 trades at a premium (0.15%) meaning the ETF is trading at a higher price than the calculated NAV.